Answers are grounded in this paper and cite their sources.
The US National Vulnerability Database (NVD) adds its own CPE configurations, CVSS score and CWE category to CVE records, and since February 2024 this enrichment has slowed. For every CVE record NVD published from January 2023 to July 2026, we measured the time from publication to the first NVD change-history event that added each field, using the NVD CVE and Change History APIs with a data cut of 2026-11-11T16:16:36Z, under a self-registered plan committed before any outcome was computed. CVEs not enriched by the cut were kept as censored observations (Kaplan-Meier) rather than dropped. Of 162,529 non-rejected CVEs, the share with an NVD-added CPE configuration within 30 days of publication was 99.98% for CVEs published 2023-01 to 2024-01, 12.0% for 2024-02 to 2024-06, 43.5% for 2024-07 to 2026-03 and 54.6% for 2026-04 to 2026-07; the lowest month was 2024-04, at 2.3%. Some CVEs in the last period may be out of scope under NVD's April 2026 policy rather than delayed; no field identifies them. NVD's own CVSS v3.1 within 30 days fell from 93.0% to 19.0% between the first and last periods, and NVD's own CWE from 71.3% to 9.6%; a CVE without NVD's value may still carry one from its CNA or from CISA. Period boundaries are NVD announcement dates, not tested causes. The record holds the note (PDF and Markdown), the registered plan and amendments (verbatim), the deviations log, stop-rule checks and pull summary (redacted of internal machine names and paths), result tables, the figure and the analysis scripts. Analysis and text by Claude (an AI model by Anthropic) for Glasp; an independent AI recomputation from the raw pages matched; no human has checked the figures. This product uses the NVD API but is not endorsed or certified by the NVD.
No takes yet. Share an insight, caveat, or question.
Keisuke Watanabe (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: